Published date: 18 May 2021

This notice was replaced on 20 October 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 20 October 2021)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Vaccines - 33651600

Location of contract

United Kingdom

Value of contract

£1

Procurement reference

2611/09/2020

Published date

18 May 2021

Closing date

16 September 2020

Closing time

12am

Contract start date

17 September 2020

Contract end date

31 December 2022

Contract type

Supply contract

Procedure type

Single tender action (below threshold)

A direct contract with a single supplier, without competition.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.

Note:

This notice corrects and supersedes a previous notice (see links section).

It does not represent a new arrangement or contract with the supplier.

More information

Attachments

Links

Award information

Awarded date

16 September 2020

Contract start date

17 September 2020

Contract end date

31 December 2022

Total value of contract

£1

This contract was awarded to 2 suppliers.

Aventis Pharma Ltd

Address

Thames Valley Park Drive
Reading
Berkshire
RG6 1PT

Reference

No reference - other

Supplier is SME?

No

Supplier is VCSE?

No

GlaxoSmithKline Biologicals S.A

Address

Rue de l'Institut 89
Rixensart
B-1330

Reference

No reference - other

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

1 Victoria Street
London
SW1H0ET
England

Email

VTFContracts@beis.gov.uk